Evidence map›Paper›PMID 39269849›Full record

ReviewFuture microbiology2024

Application of microbial enzymes in medicine and industry: current status and future perspectives.

Atieh Darbandi, Zahra Elahi, Leila Dadgar-Zankbar, Fatemeh Ghasemi, Naser Kakavandi, Sajjad Jafari, Talieh Darbandi, Roya Ghanavati

Abstract readReview
In one paragraph

Review in Future microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Atieh DarbandiMolecular Microbiology Research Center, Shahed University, Tehran, Iran.ORCID 0000-0003-2323-761X
Zahra ElahiDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Leila Dadgar-ZankbarDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Fatemeh GhasemiDepartment of Pathobiology, Division of Microbiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Naser KakavandiDepartment of Biochemistry, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Sajjad JafariDepartment of Medical Microbiology & Virology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Talieh DarbandiDepartment of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Roya GhanavatiSchool of Medicine, Behbahan Faculty of Medical Sciences, Behbahan, Iran.ORCID 0000-0002-3851-0001

Funding

Behbahan university of medical Sciences 401132
6 · The paper itself

Abstract

Microbes are a major source of enzymes due to their ability to be mass-cultivated and genetically modified. Compared with plant and animal enzymes, microbial enzymes are more stable and active. Enzymes are generally classified into six classes based on their reaction, substrate specificity and mechanism of action. In addition to their application in medicine for treating diseases, these compounds are used as anti-inflammatory, thrombolytic and digestive agents. However, challenges such as immunogenicity, tissue specificity and short

Indexed as

BacteriaEnzymesAnimalsBiotechnologyHumansEnzymesclassificationenzymesindustrymedical enzymesmicrobial enzymes

Identifiers

PMID39269849
PMCPMC11552484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.